Chartwell Investment Partners, LLC Amgen Inc Transaction History

Chartwell Investment Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 19, 2021	SELL	$233.58 - $259.14 $657,761 - $729,738	-2,816 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$221.91 - $258.6 $43,272 - $50,427	-195 Reduced 6.48%	2,816 $701,000
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $19,690 - $23,447	91 Added 3.12%	3,011 $692,000
Q2 2020 Jul 29, 2020	BUY	$197.81 - $242.74 $577,605 - $708,800	2,920 New	2,920 $689,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.